EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudieOpen Access · CC BY 4.0

Long-term outcomes after intensive care unit-treated COVID-19, influenza and respiratory sepsis in 2020 – a comparative, population-based cohort study

Franka E A Joost, Norman Rose, Aurelia Kimmig, Thomas Ruhnke, Patrik Dröge, Antje Freytag, Christian Günster, Mathias W Pletz, Martin Roesler, Philipp A Reuken, Peter Schlattmann, Konrad F R Schmidt und 5 weitere

Infection · 2026

DOI: 10.1007/s15010-025-02644-3 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Infection, 2026. Verfasst von Franka E A Joost und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany. Hauptthemen laut MEDLINE: COVID-19, Influenza, Human, Sepsis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Innovations Fund of the Federal Joint Committee, Universitätsklinikum Jena.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sepsis survivors are affected by a broad spectrum of long-term impairments, which overlap with Long-Covid and sequelae after influenza in their clinical presentation. However, we lack comparative assessments on the burden of long-term outcomes, particularly with patients being recruited from the same, contemporary patient population. Therefore we compared long-term outcomes after respiratory sepsis (RS), SARS-CoV-2–associated sepsis (SS) and influenza-associated sepsis (IS).

Methods

Retrospective, population-based cohort study. We included patients > 15 years hospitalized with RS, SS and IS between 01/2020 and 12/2020 in Germany, who received intensive care unit treatment. We compared mortality, readmissions, prevalence of diagnoses in the cognitive, psychological or medical domain, and the number of impaired domains in the 12 months post-discharge between the three survivor cohorts, adjusting for between-group differences in relevant covariates by inverse propensity score weighting based on generalized propensity scores.

Results

Our study included 12,854 patients, of which 8,201 were RS, 3,964 SS and 689 IS survivors. RS survivors had a considerably higher risk for 12-month mortality compared to SS and IS survivors (relative risk, 1.77 [95% CI, 1.54–2.03]; P < 0.001 and relative risk, 1.37 [95% CI, 1.14–1.65]; P = 0.001, respectively). They were more often rehospitalized, affected by multiple domain impairments, cognitive decline and impairments related to the severity of acute disease, e.g. complications of the tracheostoma, compared to survivors after SS and IS. RS survivors had a lower risk for being affected by medical diagnoses compared to SS. Risks for psychological diagnoses did not differ between RS and the other survivor groups.

Conclusions

Although respiratory sepsis survivors seem to be affected by more severe long-term impairments, the overall burden of post-acute sequelae among all survivor groups is high. This warrants efforts to provide targeted aftercare for all survivor populations after life-threatening infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Influenza, HumanSepsisHumansMaleFemaleMiddle AgedRetrospective StudiesAgedIntensive Care UnitsGermanyAdultSARS-CoV-2Aged, 80 and overSurvivorsCohort Studies

Stichwörter der Autor:innen

InfluenzaLong COVIDPost-Sepsis-SyndromeSepsisSurvivor

Autor:innen und Institutionen

  • Institute of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
  • Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany.
  • AOK Research Institute (WIdO), Berlin, Germany.
  • Institute of General Practice and Family Medicine, Jena University Hospital, Jena, Germany.
  • AOK-Bundesverband, Berlin, Germany.
  • Department of Internal Medicine IV (Gastroenterology, Hepatology, Infectious Diseases), Jena University Hospital, Jena, Germany.

Förderung

  • German Innovations Fund of the Federal Joint Committee
  • Universitätsklinikum Jena

Zitieren

APA

Joost, F. E. A., Rose, N., Kimmig, A., Ruhnke, T., Dröge, P., Freytag, A., Günster, C., Pletz, M. W., Roesler, M., Reuken, P. A., Schlattmann, P., Schmidt, K. F. R., Stallmach, A., Storch, J., Reinhart, K., Wedekind, L., & Fleischmann-Struzek, C. (2026). Long-term outcomes after intensive care unit-treated COVID-19, influenza and respiratory sepsis in 2020 – a comparative, population-based cohort study. Infection. https://doi.org/10.1007/s15010-025-02644-3

Vancouver

Joost FEA, Rose N, Kimmig A, Ruhnke T, Dröge P, Freytag A, et al. Long-term outcomes after intensive care unit-treated COVID-19, influenza and respiratory sepsis in 2020 – a comparative, population-based cohort study. Infection. 2026. doi:10.1007/s15010-025-02644-3

BibTeX
@article{Joost2026,
  author = {Joost, Franka E A and Rose, Norman and Kimmig, Aurelia and Ruhnke, Thomas and Dröge, Patrik and Freytag, Antje and Günster, Christian and Pletz, Mathias W and Roesler, Martin and Reuken, Philipp A and Schlattmann, Peter and Schmidt, Konrad F R and Stallmach, Andreas and Storch, Josephine and Reinhart, Konrad and Wedekind, Lisa and Fleischmann-Struzek, Carolin},
  title = {Long-term outcomes after intensive care unit-treated COVID-19, influenza and respiratory sepsis in 2020 – a comparative, population-based cohort study},
  journal = {Infection},
  year = {2026},
  doi = {10.1007/s15010-025-02644-3}
}
Kostenlos starten →